Prestige Consumer Healthcare Inc.
PBH
$66.79
-$0.17-0.25%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.10B | 1.11B | 1.12B | 1.14B | 1.12B |
| Total Other Revenue | 1.33M | 1.24M | 1.13M | 1.18M | 1.13M |
| Total Revenue | 1.10B | 1.11B | 1.12B | 1.14B | 1.12B |
| Cost of Revenue | 474.71M | 478.44M | 482.43M | 494.42M | 493.11M |
| Gross Profit | 628.90M | 632.04M | 637.72M | 643.35M | 625.12M |
| SG&A Expenses | 263.91M | 258.31M | 259.05M | 263.93M | 263.86M |
| Depreciation & Amortization | 30.17M | 29.45M | 29.72M | 30.17M | 30.76M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 768.80M | 766.20M | 771.20M | 788.52M | 787.74M |
| Operating Income | 334.81M | 344.28M | 348.95M | 349.24M | 330.50M |
| Income Before Tax | 266.68M | 285.02M | 287.55M | 284.19M | 277.55M |
| Income Tax Expenses | 80.18M | 84.19M | 74.55M | 69.58M | 63.62M |
| Earnings from Continuing Operations | 186.50 | 200.84 | 213.00 | 214.61 | 213.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 186.50M | 200.84M | 213.00M | 214.61M | 213.94M |
| EBIT | 334.81M | 344.28M | 348.95M | 349.24M | 330.50M |
| EBITDA | 364.98M | 373.73M | 378.67M | 379.41M | 361.26M |
| EPS Basic | 3.81 | 4.06 | 4.29 | 4.32 | 4.30 |
| Normalized Basic EPS | 3.56 | 3.76 | 3.78 | 3.73 | 3.49 |
| EPS Diluted | 3.79 | 4.04 | 4.27 | 4.30 | 4.27 |
| Normalized Diluted EPS | 3.53 | 3.73 | 3.75 | 3.70 | 3.46 |
| Average Basic Shares Outstanding | 196.04M | 197.75M | 198.38M | 198.79M | 198.97M |
| Average Diluted Shares Outstanding | 197.25M | 199.15M | 199.89M | 200.32M | 200.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |